Chromosomal abnormalities in 478 children with acute myeloid leukemia: Clinical characteristics and treatment outcome in a Cooperative Pediatric Oncology Group study - POG 8821

Blood

Volumn 94, Issue 11, 1999, Pages 3707-3716

  Raimondi, Susana C ^a   Chang, Myron N ^b   Ravindranath, Yaddanapudi ^b   Behm, Frederick G ^b   Gresik, Mary V ^b   Steuber, C Philip ^b   Weinstein, Howard J ^b   Carrol, Andrew J ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CHROMOSOME ABERRATION; CYTOGENETICS; FEMALE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; REMISSION; SURVIVAL RATE;

ACUTE DISEASE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; INFANT; LEUKEMIA, MYELOID; MALE; REMISSION INDUCTION;

EID: 0033485565     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Leverger G, Bernheim A, Daniel M-T, Flandrin G, Schaison G, Berger R: Cytogenetic study of 130 childhood acute nonlymphocytic leukemias. Med Pediatr Oncol 16:227, 1988
2. Raimondi SC, Kalwinsky DK, Hayashi Y, Behm FG, Mirro J Jr, Williams DL: Cytogenetics of childhood acute nonlymphocytic leukemia. Cancer Genet Cytogenet 40:13, 1989
3. Martinez-Climent JA, Lane NJ, Rubin CM, Morgan E, Johnstone HS, Mick R, Murphy SB, Vardiman JW, Larson RA, Le Beau MM, Rowley JD: Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia 9:95, 1995
4. Leblanc T, Auvrignon A, Michel G, Ansoborlo S, van den Akker J, Nelken B, Capodano A-M, Landman-Parker J, Baruchel A, Berger R, Schaison G, Leverger G: Prognosis value of cytogenetics in 250 children with acute myeloblastic leukemia treated in the LAME 89/91 protocol. Blood 88:634a, 1996 (abstr, suppl 1)
5. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A: The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Group. Blood 92:2322, 1998
6. Woods WG, Nesbit ME, Buckley J, Lampkin BC, McCreadie S, Kim TH, Piomelli S, Kersey JH, Feig S, Bernstein I, Hammond D, for the Children's Cancer Study Group: Correlation of chromosome abnormali-ties with patient characteristics, histologic subtype, and induction success in children with acute nonlymphocytic leukemia. J Clin Oncol 3:3, 1985
7. Barnard DR, Kalousek DK, Wiersma SR, Lange BJ, Benjamin DR, Arthur DC, Buckley JD, Kobrinsky N, Neudorf S, Sanders J, Miller LP, Shina DC, Hammond GD, Woods WG: Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodys-plastic syndrome in childhood: a report from the Childrens Cancer Group. Leukemia 10:5, 1996
8. The Fourth International Workshop on Chromosomes in Leukemia: A prospective study of acute nonlymphocytic leukemia. Chicago, IL, September 2-7, 1982. Cancer Genet Cytogenet 11:249, 1984
9. Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Second MIC Cooperative Study Group. Report on the Workshop held in Leuven, Belgium, September 15-17, 1986. Cancer Genet Cytogenet 30:1, 1988
10. Fenaux P, Chomienne C, Degos L: Acute promyelocytic leukemia. Biology and treatment. Semin Oncol 24:92, 1997
11. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH: All- trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 337:1021, 1997
12. Kalwinsky DK, Raimondi SC, Schell MJ, Mirro J Jr, Santana VM, Behm F, Dahl GV, Williams D: Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. J Clin Oncol 8:75, 1990
13. Head DR: Revised classification of acute myeloid leukemia. Leukemia 10:1826, 1996
14. Ritter J: Acute myeloid leukaemias: Eur J Cancer 34:862, 1998
15. Ravindranath Y, Yeager AM, Chang MN, Steuber CP, Krischer J, Graham-Pole J, Carroll AJ, Inoue S, Camitta B, Weinstein H, for the Pediatric Oncology Group: Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. N Engl J Med 334:1428, 1996
16. Carroll AJ, Castleberry RP, Crist WM: Lack of association between abnormalities of the chromosome 9 short arm and either "lymphomatous" features or T cell phenotype in childhood acute lymphocytic leukemia. Blood 69:735, 1987
17. Raimondi SC, Mathew S, Pui C-H: Cytogenetics as a diagnostic aid for childhood hematologic disorders, in Hanausek M, Walaszek Z (eds): Methods in Molecular Medicine: Tumor Marker Protocols, vol 14. Totowa, NJ, Humana, 1998, p 209
18. Mitelman F: ISCN 1991. Guidelines for Cancer Cytogenetics (1991). Basel, Switzerland, Karger, 1991
19. Mitelman F: ISCN 1995. An International System for Human Cytogenetic Nomenclature (1995). Basel, Switzerland, Karger, 1995
20. Kaplan EL, Meier P: Nonparametric estimation for incomplete observations. J Am Statist Assoc 53:457, 1958
21. Peto R, Peto J: Asymptotically efficient rank invariate test procedures. J Royal Stat Society 135:185, 1972
22. Armitage P: Statistical Method in Medical Research. Boston, MA, Blackwell Scientific, 1971
23. Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil K, Mohamed A, Chung A, Paietta E, Willman C, Head DR, Forman SJ, Appelbaum FR: Karyotypic analysis predicts outcome of pre- and post-remission therapy in adult acute myeloid leukemia (AML): A SWOG/ECOG intergroup study. Blood 92:678a, 1998 (abstr, suppl 1)
24. Rubin CM, Larson RA, Anastasi J, Winter JN, Thangavelu M, Vardiman JW, Rowley J, Le Beau MM: t(3;21)(q26;q22): A recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 76:2594, 1990
25. Kong X-T, Ida K, Ichikawa H, Shimizu K, Ohki M, Maseki N, Kaneko Y, Sako M, Kobayashi Y, Tojou A, Miura I, Kakuda H, Funabiki T, Horibe K, Hamaguchi H, Akiyama Y, Bessho F, Yanagisawa M, Hayashi Y: Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript. Blood 90:1192, 1997
26. Shurtleff SA, Meyers S, Hiebert SW Raimondi SC, Head DR, Willman CL, Wolman S, Slovak ML, Caroll AJ, Behm F, Hulshof MG, Motroni TA, Okuda T, Liu P, Collins FS, Downing JR: Heterogeneity in CBFβ/MYHII fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia. Blood 85:3695, 1995
27. Ritter M, Thiede C, Schakel U, Schmidt M, Alpen B, Pascheberg U, Mohr B, Ehninger G, Neubauer A, for the AML-SHG Study Group: Underestimation of inversion (16) in acute myeloid leukaemia using standard cytogenetics as compared with polymerase chain reaction: results of a prospective investigation. Br J Haematol 98:969, 1997
28. Rowley JD, Diaz MO, Espinosa R III, Patel YD, van Melle E, Ziemin S, Taillon-Miller P, Lichter P, Evans GA, Kersey JH, Ward DC, Domer PH, Le Beau MM: Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: Identification of 11q23 translocalion breakpoints with a yeast artificial chromosome. Proc Natl Acad Sci USA 87:9358, 1990
29. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H, Zieman-van der Poel S, Kaneko Y, Morgan R, Sandberg AA, Chaganti RSK, Larson RA, Le Beau MM, Diaz MO, Rowley JD: Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 329:909, 1993
30. Mathew S, Behm FG, Dalton J, Raimondi SC: Comparison of cytogenetics, Southern blotting, and fluorescence in situ hybridization (FISH) as methods for detecting MLL gene rearrangements in children with acute leukemias and 11q23 abnormalities. Leukemia (in press)
31. Dastugue N, Payen C, Lafage-Pochitaloff M, Bernard P, Leroux D, Huguet-Rigal F, Stoppa A-M, Marit G, Molina L, Michallet M, Maraninchi D, Attal M, Reiffers J, for the BGMT Group: Prognostic significance of karyotype in de novo adult acute myeloid leukemia. Leukemia 9:1491, 1995
32. Stasi R, Venditti A, Del Poeta G, Aronica G, Dentamaro T, Cecconi M, Stipa E, Scimo MT, Masi M, Amadori S: Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: Analysis of prognostic factors. Cancer 77:476, 1996
33. Mitelman F, Brandt L, Nilsson PG: Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia. Blood 52:1229, 1978
34. Martinez-Climent JA, Espinosa R III, Thirman MJ, Le Beau MM, Rowley JD: Abnormalities of chromosome band 11q23 and the MLL gene in pediatric myelomonocytic and monoblastic leukemias. Identification of the t(9;11) as an indicator of long survival. J Pediatr Hematol Oncol 17:277, 1995
35. Behm FG, Shurtleff SA, Raimondi SC, Ribeiro RC, Krance R, Jayawardene DA, Head DR, Mirro J, Srivastava DK, Downing JR: A retrospective molecular study of the frequency of AML1/ETO, CBFB/ MYHII, PML/RARA, and rearrangement of MLL in childhood de novo AMLand comparison with survival. Blood 90:63a, 1997 (abstr, suppl 1)
36. Mrozek K, Heinonen H, Lawrence D, Carroll AJ, Koduru PR, Rao KW, Strout MP, Hutchison RE, Moore JO, Mayer RJ, Schiffer CA, Bloomfield CD: Adult patients with de novo acute myeloid leukemia and t(9;11)(p22;q23) have a superior outcome to patients with other translocations involving band 11q23: A Cancer and Leukemia Group B study. BJood 90:4532, 1998
37. Raimondi SC, Ravindranath Y, Chang M, Behm FG, Weinstein HJ, Carroll A: EFS does not differ significantly among 11q23 subgroups in childhood AML: Pediatric Oncology Group study 8821. Blood 92:481a, 1998 (abstr, suppl 1)